IDEXX LABORATORIES INC /DE - Common Stock (IDXX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
IDXX on Nasdaq
Shares outstanding
80,841,255
Price per share
$676.53
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
71,945,340
Total reported value
$45,941,105,840
% of total 13F portfolios
0.04%
Share change
-2,397,886
Value change
-$1,426,822,438
Number of holders
1,282
Price from insider filings
$676.53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 9.4% $3,297,923,861 7,599,078 BlackRock, Inc. 31 Mar 2025

As of 30 Sep 2025, 1,282 institutional investors reported holding 71,945,340 shares of IDEXX LABORATORIES INC /DE - Common Stock (IDXX). This represents 89% of the company’s total 80,841,255 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 9,962,025 +0.87% 0.1% $6,364,638,153
BlackRock, Inc. 10% 8,205,011 -2% 0.09% $5,242,099,447
STATE STREET CORP 4.4% 3,517,670 -1% 0.08% $2,247,404,186
Fundsmith LLP 3.2% 2,610,457 -1.1% 8.4% $1,667,794,873
GEODE CAPITAL MANAGEMENT, LLC 3.1% 2,497,676 +1.4% 0.1% $1,591,098,712
Bank of New York Mellon Corp 2.5% 2,056,680 +42% 0.24% $1,313,992,065
BAMCO INC /NY/ 2.3% 1,884,129 -7.3% 3.2% $1,203,751,177
MORGAN STANLEY 2% 1,622,490 -2.5% 0.06% $1,036,595,623
Invesco Ltd. 1.6% 1,320,263 +14% 0.13% $843,502,663
PRINCIPAL FINANCIAL GROUP INC 1.6% 1,315,722 +17% 0.42% $840,638,344
POLEN CAPITAL MANAGEMENT LLC 1.4% 1,127,147 -5.7% 2.3% $720,123,065
BLAIR WILLIAM & CO/IL 1.3% 1,031,786 -4.5% 1.8% $659,197,463
NORTHERN TRUST CORP 1.2% 942,368 -1.5% 0.08% $602,069,492
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 1.1% 875,549 -18% 0.12% $559,379,500
JPMORGAN CHASE & CO 1.1% 869,930 +60% 0.04% $555,801,572
GOLDMAN SACHS GROUP INC 0.88% 711,942 +21% 0.07% $454,852,946
AMERICAN CENTURY COMPANIES INC 0.87% 705,158 -17% 0.23% $450,518,395
PRICE T ROWE ASSOCIATES INC /MD/ 0.86% 694,208 +29% 0.05% $443,524,000
Capital Research Global Investors 0.85% 690,601 +0.82% 0.08% $441,218,073
FUNDSMITH INVESTMENT SERVICES LTD. 0.85% 688,357 -19% 6.9% $439,784,404
Legal & General Group Plc 0.84% 675,535 +4.1% 0.1% $431,592,555
Amundi 0.73% 592,599 -12% 0.12% $372,021,801
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.71% 575,930 +3.5% 0.06% $367,955,918
FRANKLIN RESOURCES INC 0.71% 572,978 -3.3% 0.09% $366,069,631
DIMENSIONAL FUND ADVISORS LP 0.67% 544,185 -2.3% 0.07% $347,641,219

Institutional Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 751,941 $509,684,885 +$92,878,677 $676.53 85
2025 Q3 71,945,340 $45,941,105,840 -$1,426,822,438 $638.89 1,282
2025 Q2 74,492,454 $39,944,909,126 +$622,390,438 $536.34 1,224
2025 Q1 73,764,672 $30,958,486,481 +$779,942,482 $419.95 1,129
2024 Q4 71,835,659 $29,724,021,447 -$973,691,253 $413.44 1,115
2024 Q3 72,771,836 $36,698,542,671 -$866,484,087 $505.22 1,105
2024 Q2 74,742,498 $36,407,539,797 +$1,194,076,623 $487.20 1,100
2024 Q1 72,528,628 $39,086,467,213 -$62,993,917 $539.93 1,141
2023 Q4 72,729,572 $40,349,913,998 -$603,765,389 $555.05 1,143
2023 Q3 74,019,658 $32,363,649,715 +$430,812,418 $437.27 1,056
2023 Q2 73,042,621 $36,667,385,940 +$94,841,652 $502.23 1,059
2023 Q1 72,713,915 $36,334,265,012 -$355,801,839 $500.08 1,046
2022 Q4 73,497,514 $30,011,391,318 +$172,319,687 $407.96 982
2022 Q3 73,626,131 $24,002,744,883 -$83,281,427 $325.80 900
2022 Q2 73,767,652 $25,881,144,178 +$454,367,814 $350.73 940
2022 Q1 72,572,264 $39,690,896,632 +$485,420,646 $547.06 1,013
2021 Q4 71,508,034 $47,013,671,922 -$115,610,874 $658.46 1,084
2021 Q3 71,564,445 $44,507,146,691 -$836,578,782 $621.90 1,055
2021 Q2 72,890,084 $46,029,916,801 +$144,499,493 $631.55 1,021
2021 Q1 72,631,314 $35,536,251,001 -$362,776,244 $489.31 1,004
2020 Q4 73,683,435 $36,820,146,126 +$237,064,045 $499.87 957
2020 Q3 73,270,641 $28,787,297,170 -$575,176,884 $393.11 835
2020 Q2 74,703,783 $24,698,206,219 -$351,542,875 $330.16 788
2020 Q1 75,867,270 $18,376,382,067 +$291,732,808 $242.24 739
2019 Q4 74,418,598 $19,431,403,452 -$142,779,457 $261.13 745
2019 Q3 74,857,557 $20,354,241,028 -$168,074,478 $271.93 711
2019 Q2 75,445,232 $20,769,443,657 +$102,922,643 $275.33 704
2019 Q1 76,138,903 $17,024,720,869 +$138,025,921 $223.60 674
2018 Q4 71,201,603 $13,245,107,465 +$160,819,000 $186.02 661
2018 Q3 74,466,337 $18,588,758,229 -$154,218,194 $249.66 687
2018 Q2 79,592,778 $17,345,258,239 -$263,188,794 $217.94 656
2018 Q1 76,258,995 $14,592,016,610 +$65,147,323 $191.39 639
2017 Q4 76,285,245 $11,928,011,765 -$95,029,002 $156.38 605
2017 Q3 76,358,980 $11,868,339,082 -$66,961,009 $155.49 570
2017 Q2 77,242,563 $12,469,740,345 -$154,025,637 $161.42 577
2017 Q1 79,021,291 $12,211,187,005 +$1,416,402,753 $154.61 533
2016 Q4 78,092,711 $9,161,802,342 -$400,720,232 $117.27 514
2016 Q3 81,599,118 $9,194,716,689 -$104,867,796 $112.73 472
2016 Q2 82,484,516 $7,660,607,605 -$373,404,549 $92.86 432
2016 Q1 86,960,429 $6,809,529,287 -$233,929,280 $78.32 369
2015 Q4 89,930,874 $6,557,487,487 -$72,543,183 $72.92 345
2015 Q3 91,025,347 $6,757,325,682 -$65,778,945 $74.25 351
2015 Q2 90,496,455 $5,804,305,294 +$2,820,875,260 $64.14 345
2015 Q1 45,808,495 $7,072,744,385 -$67,169,242 $154.48 339
2014 Q4 46,302,363 $6,868,103,193 -$170,187,877 $148.27 345
2014 Q3 47,691,812 $5,619,567,343 -$92,106,412 $117.83 314
2014 Q2 48,342,928 $6,456,581,609 -$316,805,338 $133.57 304
2014 Q1 50,628,842 $6,146,282,012 -$73,672,510 $121.40 310